CONTACT US
PanCAN Signs on to Research! America Statement | 2/25/25
The Pancreatic Cancer Action Network (PanCAN) has signed onto a letter from Research! America to join forces with 600 organizations and over 3,500 individuals nationwide in a powerful call to action. Together, we are demanding that Congressional leaders prioritize immediate and robust funding for the National Institutes of Health (NIH) in the Fiscal Year 2025 appropriations bill. This letter, sent directly to the leaders of the House and Senate Appropriations Committees, is a unified, unwavering voice speaking for the future of medical research and innovation. The message is clear: Congress must act now to secure vital funding for NIH and protect crucial safeguards against harmful cuts to NIH grantee Facilities and Administrative costs. The time for action is now—pancreatic cancer patients are depending on it.
PanCAN Signs on to OVAC Statement | 2/21/25
Today, the Pancreatic Cancer Action Network (PanCAN) signed on to a statement from One Voice Against Cancer (OVAC), a collaboration of national non-profit organizations representing millions of Americans, delivering a unified message to Congress and the White House on the need for increased cancer-related appropriations. The statement unites the cancer community in opposing recent executive actions and calling on both the administration and members of Congress to work together to ensure that we continue to advance progress against pancreatic cancer and all other cancers:
“As members of organizations unified in our support for the life-saving power of cancer research, we oppose recent executive actions that indisputably jeopardize progress in the fight against cancer today and for years to come. Cuts to our nation’s health and research infrastructure funding and widespread layoffs at the National Institutes of Health, including the National Cancer Institute, the Centers for Disease Control and Prevention, and the Food and Drug Administration will have a devastating impact on the more than 2 million people who will be diagnosed with cancer this year alone. The negative impact of cuts will be felt across the country where research generates significant economic activity and jobs in every state. The United States also risks losing its global competitive edge in biomedical research as these actions threaten to halt or end clinical trials, shutter sophisticated medical labs across the country, force young researchers to reconsider or abandon academic research and jeopardize Americans’ access to the latest and best medical advancements, including new cancer treatments, for years to come.
“We stand ready as a community to work with the administration and Congress to ensure we continue the progress that has driven a 34% reduction in cancer mortality over the past two decades. We call on the administration to stand with patients, researchers, caregivers, physicians, and nurses by reversing these harmful actions and continuing our nation’s longstanding bipartisan support for cancer research and prevention.”
